Drug Shortage Report for CEFTIN - TAB 250MG
| Report ID | 35768 |
| Drug Identification Number | 02212277 |
| Brand name | CEFTIN - TAB 250MG |
| Common or Proper name | cefuroxime axetil tablets |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CEFUROXIME |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60's |
| ATC code | J01DC |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-01-11 |
| Estimated end date | Unknown |
| Actual end date | 2020-07-20 |
| Shortage status | Resolved |
| Updated date | 2020-07-24 |
| Company comments | product has been discontinued. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2018-04-04 | English | Compare |
| v2 | 2018-01-12 | French | Compare |
| v1 | 2018-01-12 | English | Compare |